Mindfulness in Mood Dysregulated Youth

May 17, 2016 updated by: Melissa Delbello, University of Cincinnati

Neural Basis of Mindfulness in Mood Dysregulated Youth

Mindfulness group therapy can help children with mood irregularities and family history of bipolar disorder.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Mindfulness Based Cognitive Therapy (MBCT) is a manualized psychotherapeutic intervention that is a combination of mindfulness techniques and cognitive behavioral therapy. MBCT-C, which is mindfulness based cognitive based therapy for children, involves weekly group sessions, home practice, and the core curriculum of formal mindfulness practices (e.g. body scan, sitting, movement and walking meditations). Group sessions will involve guided meditation practices, instructor-led discussion of experiences and psychoeducation. By fopstering the ability to pay close attention to thoughts, emotions and body sensations, participants learn to make better choices to deal with stress, anxiety, depression, pain and other challenges. This can allow them to more effectively use the principles of cognitive behavioral therapy.

Twelve children aged 10-17 with mood dysregulation and a bipolar parent will be in the study for 12 weeks. There will be two groups receiving intervention: one group recruited from the community and one group recruited from a known high-risk cohort.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cincinnati, Ohio, United States, 45219
        • University of Cincinnati

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

To be included in this study, subjects must meet the following criteria:

  1. Ages 10 -17 years; inclusive at the time of consent
  2. At least one biological parent with bipolar I disorder, confirmed with the SCID-P/L
  3. CDRS-R score > 28 or YMRS score > 12 or ERC score > 36 at screening and baseline since clinically significant elevation on any of these scales suggests mood dysregulation
  4. Fluent in English
  5. Provision of written informed consent/assent as previously described
  6. Agrees to participate in at least 75% of sessions.

Exclusion Criteria:

  1. Previously documented diagnosis of mental retardation or an IQ <70
  2. Any lifetime DSM-V diagnosis of bipolar disorder, schizophrenia or other psychotic disorder
  3. Previous participation in a mindfulness-based treatment, including MBCT-C
  4. A substance use disorder (except nicotine or caffeine) within the past 3 months
  5. Judged clinically to be at risk from suicide as defined as having active suicidal ideation, intent or plan, or a serious suicide attempt within 30 days, or a baseline CDRS-R suicide score of >3
  6. Concurrent treatment with psychotropic medications that have been adjusted during the 30 days prior to screening or are anticipated during the course of study participation
  7. Psychotherapy initiated within 2 month prior to screening or plan to initiate psychotherapy during study participation
  8. Significant psychiatric symptoms that require hospitalization
  9. Mood symptoms resulting from acute medical illness or acute intoxication or withdrawal from drugs or alcohol as determined by medical evaluation or rapid symptom resolution
  10. Female patients who are either pregnant or lactating; All girls will have a urine pregnancy test prior to MR scans
  11. Any contraindication to an MRI scan (e.g., metal clips, braces or claustrophobia)
  12. Neurological disorders (e.g. epilepsy) or severe head trauma resulting in loss of consciousness for > 10 minutes or any unstable medical illness.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MBCT-C Therapy
Mindfulness Based Cognitive Therapy for Children is a manualized psychotherapeutic intervention that combines mindfulness techniques with certain features of cognitive behavioral therapy. This particular protocol for youth includes weekly group sessions, regular home practice, and the core curriculum of formal mindfulness practices (e.g., body scan, sitting, movement, and walking meditations).
Mindfulness Based Cognitive Therapy for Children is a manualized psychotherapeutic intervention that combines mindfulness techniques with certain features of cognitive behavioral therapy. This particular protocol for youth includes weekly group sessions, regular home practice, and the core curriculum of formal mindfulness practices (e.g., body scan, sitting, movement, and walking meditations).
Other Names:
  • Mindfulness Based Cognitive Therapy-Children

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in ERC
Time Frame: 12 weeks
Change from baseline to endpoint ( 12 weeks) in ratings on the Emotion Regulation Checklist
12 weeks
Change in CDRS-R
Time Frame: 12 weeks
Change from baseline to endpoint (12 weeks) on the ratings on the Children's Depression Rating Scale-Revised.
12 weeks
Change in YMRS
Time Frame: 12 weeks
Change from baseline to endpoint (12 weeks) in ratings on the Young Mania Rating Scale.
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in amygdala, insula, and prefrontal activation.
Time Frame: 12 weeks
We will examine baseline to endpoint changes in task related VLPFC, amygdala, and insula activation. We will examine associations among changes in activation in these brain regions and changes in mood regulation rating scale scores.Additionally, we will examine changes in seed-based resting state connectivity measures using amygdala and insula as the seeds and examining connectivity with VLPFC regions. Finally, we will use correlation to assess associations among changes in resting state connectivity of these regions and changes in mindfulness measures.
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Melissa P DelBello, MD, University of Cincinnati
  • Principal Investigator: Sian Cotton, PhD, University of Cincinnati

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

April 18, 2014

First Submitted That Met QC Criteria

April 21, 2014

First Posted (Estimate)

April 23, 2014

Study Record Updates

Last Update Posted (Estimate)

May 18, 2016

Last Update Submitted That Met QC Criteria

May 17, 2016

Last Verified

September 1, 2015

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bipolar Disorder

Clinical Trials on MBCT-C Therapy

Subscribe